Stock Under $10 with 50-100% upside potential - 14 Days FREE!

3 Stocks Under $5 Making Big Moves

Stock quotes in this article: ROSG, IMUC, OXGN 

ImmunoCellular Therapeutics

ImmunoCellular Therapeutics (IMUC) is a development-stage company which is seeking to develop and commercialize new therapeutics to fight cancer using the immune system. This stock is trading up 7.8% to $2.34 in recent trading.

Today's Range: $2.24-$2.39

52-Week Range: $1.51-$4.00

Volume: 1.07 million

Three-Month Average Volume: 435,416

From a technical perspective, IMUC is ripping higher here right above its 50-day moving average of $2.05 with monster upside volume. This move has started to push shares of IMUC into breakout territory, since the stock has taken out some near-term overhead resistance levels at $2.27 to $2.28. Shares of IMUC are now quickly moving within range of another near-term breakout trade. That trade will hit if IMUC manages to take out its 200-day moving average of $2.65 with high volume.

Traders should now look for long-biased trades in IMUC as long as it's trending above $2.27 to $2.28, and then once it sustains a move or close above its 200-day at $2.65 with volume that hits near or above 435,416 shares. If that breakout hits soon, then IMUC will set up to re-test or possibly take out its next major overhead resistance levels $2.93 to $2.94. Any high-volume move above those levels will then put $3.26 to $3.50 into range for shares of IMUC.

Rosetta Genomics

Rosetta Genomics (ROSG) develops diagnostic tests and therapeutic tools. Its product portfolio comprises of tests such as miRview mets2 / mets, miRview squamous, miRview meso and miRview kidney. This stock is trading up 2% to $4.63 in recent trading.

Today's Range: $4.65-$4.76

52-Week Range: $1.40-$23.43

Volume: 136,000

Three-Month Average Volume: 553,442

From a technical perspective, ROSG is moving modestly higher here back above its 50-day moving average of $4.61 with lighter-than-average volume. This move is quickly pushing shares of ROSG within range of triggering a near-term breakout trade. That trade will hit if ROSG manages to take out some near-term overhead resistance levels at $4.95 to $5 with high volume.

Traders should now look for long-biased trades in ROSG as long as it's trending above its 50-day at $4.61, and then once it sustains a move or close above those breakout levels with volume that hits near or above 553,442 shares. If that breakout triggers soon, then ROSG will set up to re-test or possibly take out its next major overhead resistance levels at $5.50 to $5.98. Any high-volume move above $5.98 will then put $6.27 to $7 into range for shares of ROSG.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,239.36 -55.14 -0.36%
NASDAQ 3,443.01 -16.41 -0.47%
S&P 500 1,642.60 -7.91 -0.48%
US 10 Yr 2.005% -0.018

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs